DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Needle-Free Drug Delivery Market 2017-2021" report to their offering.
The global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.
This report, Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.
One trend in the market is increasing outsourcing. Companies are outsourcing secondary processes such as manufacturing, logistics, and sterilization to third parties to cut down costs and focus on improving their core product offerings. Many companies such as PharmaJet and Antares Pharma have outsourced their manufacturing operations to third parties.
According to the report, one driver in the market is increasing incidence of needle stick injuries. According to CDC estimates 12 billion injections are administered annually worldwide. Unsafe injections are resulting in large proportion of bloodborne disease transmission. The percentage of unsafe injections range from 15% in Eastern Europe to 50% in Asia. The contaminated and unsafe needle injections are causing millions of deaths and disability-adjusted life years in healthcare settings.
- Endo Pharmaceuticals
- Antares Pharma
- Inovio Pharmaceuticals
Other prominent vendors:
- Akra Dermojet
- Consort Medical
- Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
- PenJet Corporation
- D'Antonio Consultants International
European Pharma Group
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product/technology
Part 07: Market segmentation by application
Part 08: Geographical segmentation
Part 09: Decision framework
Part 10: Drivers and challenges
Part 11: Market trends
Part 12: Vendor landscape
Part 13: Key vendor analysis
For more information about this report visit https://www.researchandmarkets.com/research/ksfjcp/global